Sample 22
Homo sapiens
Protocols: Whole blood was taken at each participant visit, each participant had had at least two PAXgene tubes of whole blood collected for RNA extraction. All patients were given etanercept subcutaneous administration 25mg twice weekly (administered either as 25mg twice weekly or 50mg once weekly). miRNA were extracted from blood using miRNeasy blood kits according to manufacturers' protocol. RNA was quantified and quality controlled (assuring a RIN>8) using the Agilent RNA 6000 Nano Kit (Agilent Technologies, Waldbronn, Germany) using the manufacturer's protocol. TruSeq Small RNA library preparation (Illumina)
ENA-FIRST-PUBLIC
2018-09-21T17:02:08Z
ENA-LAST-UPDATE
2018-09-11T13:57:21Z
External Id
SAMEA4893572
INSDC center name
QMUL
INSDC first public
2018-09-21T17:02:08Z
INSDC last update
2018-09-11T13:57:21Z
INSDC status
public
Submitter Id
E-MTAB-6428:Sample 22
age
52
broker name
ArrayExpress
clinical information
psoriasis area severity index 12.8
common name
human
disease
psoriasis
individual
AFOX09
organism part
blood
sample name
E-MTAB-6428:Sample 22
scientific_name
Homo sapiens
sex
female
treatment
etanercept; 50 milligram